A Signature-based Algorithm for computing Computing Gr\"obner Bases over Principal Ideal Domains
Maria Francis, Thibaut Verron

TL;DR
This paper introduces a signature-based algorithm for computing Gr"obner bases over principal ideal domains, extending existing methods from fields to more general rings, with proofs of correctness and initial experimental validation.
Contribution
It presents the first proof-of-concept signature-based algorithm for Gr"obner bases over integral domains, adapting M"oller's algorithm and ensuring correctness over PIDs.
Findings
Algorithm performs reductions with non-decreasing signatures.
Correctness and termination are proven for PIDs.
Initial experiments suggest potential applicability to UFDs.
Abstract
Signature-based algorithms have become a standard approach for Gr\"obner basis computations for polynomial systems over fields, but how to extend these techniques to coefficients in general rings is not yet as well understood. In this paper, we present a proof-of-concept signature-based algorithm for computing Gr\"obner bases over commutative integral domains. It is adapted from a general version of M\"oller's algorithm (1988) which considers reductions by multiple polynomials at each step. This algorithm performs reductions with non-decreasing signatures, and in particular, signature drops do not occur. When the coefficients are from a principal ideal domain (e.g. the ring of integers or the ring of univariate polynomials over a field), we prove correctness and termination of the algorithm, and we show how to use signature properties to implement classic signature-based criteria to…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Code & Models
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsPolynomial and algebraic computation · Cryptography and Residue Arithmetic · Cancer Treatment and Pharmacology
